Lakeway, TX -- (SBWIRE) -- 03/01/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-
NPS Pharmaceuticals, Inc.(NASDAQ:NPSP) shares gained 4.04% to $7.98.The Company, on Feb. 21, reported fourth quarter EPS of ($0.14), $0.05 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $27.1 million versus the consensus estimate of $28.93 million. For the year 2013, the company expects its operating expenses, to be between $135 and $145 million.
How Should Investors Trade NPSP After The Recent Movement? Find Out Here
Denison Mines Corp (USA) (NYSEAMEX:DNN) shares jumped 4.03% and closed at $1.29 in the last trading session. The company, on Jan. 31, announced the closing of its previously announced acquisition of the outstanding common shares of JNR Resources Inc. (JNR). The transaction was completed pursuant to a plan of arrangement (the Arrangement) in accordance with the Business Corporations Act (British Columbia), which was approved by the British Columbia Supreme Court yesterday. Securityholders of JNR approved the Arrangement on January 28, 2013.
Is DNN Strong Buy After The Recent Strong Gains? Get Free Trend Analysis Here
Mentor Graphics Corp (NASDAQ:MENT) shares gained 3.81% to $17.71 after the company yesterday reported fourth quarter net income of $61.75 million or $0.49 per share, as compared to $57.82 million or $0.52 per share in the prior-year quarter. Adjusted net income for the quarter was $66.25 million or $0.58 per share, compared to $64.70 million or $0.58 per share in the year-ago quarter. Total revenues for the quarter grew to $331.24 million from $320.36 million in the same quarter last year. Analysts expected the company to report earnings of $0.55 per share on revenue of $343.18 million.
Is MENT a Buying Opportunity After The Recent Plunge? Don’t Miss Out Our Latest Report Here
Dendreon Corporation (NASDAQ:DNDN) shares increased 3.76% to $5.79.The company, on Feb. 25, provided a quarterly loss versus a year-ago profit as revenue fell and restructuring costs weighed on the biotechnology company. The fourth-quarter loss was $38.7 million, or 26 cents per share, compared with a profit of $38.1 million, or 26 cents per share. Quarterly revenue fell to $85.5 million from $202.1 million a year ago.
How Should Investors Trade DNDN After The Latest Earnings Report? Find Out Here
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)